Rosenkrans, Zachary T.
Massey, Christopher F.
Bernau, Ksenija
Ferreira, Carolina A.
Jeffery, Justin J.
Schulte, Jefree J.
Moore, Melissa
Valla, Frank
Batterton, Jeanine M.
Drake, Christopher R.
McMillan, Alan B.
Sandbo, Nathan
Pirasteh, Ali
Hernandez, Reinier http://orcid.org/0000-0002-0729-2179
Funding for this research was provided by:
National Cancer Institute (T32CA009206)
National Institutes of Health (R01HL146402)
U.S. Department of Defense (W81XWH1910285)
National Cancer Institute (P30CA014520)
Article History
Received: 14 December 2021
Accepted: 23 April 2022
First Online: 12 May 2022
Declarations
:
: All animal studies were conducted under protocols approved by the Institutional Animal Care and Use Committee at the University of Wisconsin-Madison.
: Not applicable.
: A. P. receives departmental research support from GE Healthcare. A. P. serves as a consultant for TheraCea and Sanofi Genzyme. M. M., F. V., and C. R. D. are all current (F. V.) or former employees (M. M., C. R. D.) at SOFIE. All other authors declare no conflicts of interest.